Form4insider filings, from the source

SEC Form 4 · accession 0001055726-18-000003

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Niranjan Sardesai
Officer — Chief Operating Officer
Period of report
Mar 5, 2018
Accepted (ET)
Mar 7, 2018 · 7:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001055726

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 5, 2018M8,333—A93,416D
Common StockMar 5, 2018F2,815$4.29D90,601D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitF1—Mar 5, 2018M8,333D——Common Stock8,3330D
Common Stock OptionF3$4.29Mar 5, 2018A126,500AMar 5, 2018Mar 5, 2028Common Stock126,500126,500D
Restricted Stock UnitF4—Mar 5, 2018A82,700A——Common Stock82,70082,700D

Explanation of responses